HIDRADENITIS SUPPURATIVA (HS)
Clinical trials for HIDRADENITIS SUPPURATIVA (HS) explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA (HS) trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA (HS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for painful skin condition in major trial
Disease control CompletedThis Phase 3 study tested an oral medication called povorcitinib for people with moderate to severe hidradenitis suppurativa (HS), a chronic, painful skin condition. The 619 participants took either the drug or a placebo for 12 weeks, with many continuing for an additional 42 wee…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Breakthrough drug shows promise for painful skin condition in major trial
Disease control CompletedThis Phase 3 clinical trial tested an oral medication called povorcitinib for people with moderate to severe hidradenitis suppurativa (HS), a chronic inflammatory skin condition. The study involved 608 participants who had not responded well to previous treatments. Over 12 weeks,…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC
-
AI steps in to help doctors spot rare skin diseases
Diagnosis CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors diagnose skin conditions more accurately, especially rare ones like generalized pustular psoriasis. Fifteen doctors reviewed 100 patient images, first giving their own diagnosis and then seeing the …
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
AI helps family doctors spot skin cancer
Diagnosis CompletedThis study tested whether an artificial intelligence (AI) tool could help primary care doctors more accurately diagnose various skin conditions, including skin cancers like melanoma. Nine doctors reviewed 30 skin images, first giving their own diagnosis and then reviewing the AI'…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
New dressing tested for painful skin condition
Symptom relief CompletedThis small study tested a combination wound dressing for people with hidradenitis suppurativa (HS), a painful skin condition. Five adult participants with non-healing HS wounds used the dressing at home for eight weeks. Researchers measured if the wounds got smaller and if the dr…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Scientists search skin for clues to painful disease
Knowledge-focused CompletedThis study aimed to understand the molecular causes of hidradenitis suppurativa (HS), a painful and chronic inflammatory skin disease. Researchers compared small skin samples from 15 people with HS to samples from 15 healthy people. They analyzed the samples to see how specific g…
Matched conditions: HIDRADENITIS SUPPURATIVA (HS)
Sponsor: Trakya University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC